Landos Biopharma Inc (LABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Operating Expenses | 6,513 | 7,829 | 11,266 | 14,953 | 20,395 |
| Operating Income | -6,513 | -7,829 | -11,266 | -14,953 | -20,395 |
| Interest Expense | 0 | 67 | 0 | 0 | 0 |
| Other Income | 1,281 | 0 | -18 | 89 | 298 |
| Pre-tax Income | -5,232 | -7,896 | -11,284 | -14,864 | -20,097 |
| Net Income Continuous | -5,232 | -7,896 | -11,284 | -14,864 | -20,097 |
| Net Income | $-5,232 | $-7,896 | $-11,284 | $-14,864 | $-20,097 |
| EPS Basic Total Ops | -1.30 | -1.96 | -2.80 | -3.70 | -4.40 |
| EPS Basic Continuous Ops | -1.30 | -1.96 | -2.80 | -3.69 | -4.53 |
| EPS Diluted Total Ops | -1.30 | -1.96 | -2.80 | -3.70 | -4.40 |
| EPS Diluted Continuous Ops | -1.30 | -1.96 | -2.80 | -3.69 | -4.50 |
| EPS Diluted Before Non-Recurring Items | -1.30 | -2.00 | -2.80 | N/A | N/A |
| EBITDA(a) | $-6,418 | $-7,323 | $-10,805 | $-14,288 | $-20,376 |